BioPharma announced that its licensee Celly Nutrition Corporation, the company behind unbuzzd announced that it has engaged a leading New York Investment Bank to raise up to $10 million USD in capital and explore an initial public offering on a major US public exchange, subject to requisite regulatory approval. Quantum BioPharma Ltd. retains ownership of 25.71% of Celly Nutrition.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum BioPharma’s unbuzzd™ Shows Promising Results in Clinical Trial
- Quantum Group announces results from unbuzzd trial
- Five new option listings and option delistings on January 21st
- Quantum BioPharma Closes Third Tranche Offering with Amended Terms
- Quantum BioPharma Advances Legal Actions Against Former CEO